{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:34:22Z","timestamp":1776875662396,"version":"3.51.2"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Dasatinib associated lymphadenopathy (DAL) is a rare adverse event in chronic myeloid leukemia patients (CML). A case of voluminous lymphadenopathy in the context of DAL is presented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 40-year-old male patient was diagnosed with BCR-ABL1 positive chronic stage CML 2 years ago and achieved complete molecular response on nilotinib, which was switched to dasatinib due to nilotinib intolerance. After 5 months on dasatinib, the patient presented with a large mass in the axillary region.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Common infectious and autoimmune etiologies of lymphadenopathy were ruled out. The positron emission tomography\/computed tomography (PET\/CT) demonstrated a hypermetabolic lymphadenopathy highly suspicious of lymphoma. The subsequent biopsy excluded lymphoma or extramedullary blastic transformation of CML and revealed reactive lymphadenopathy with mixed (cortical and paracortical) pattern. Clinical history and clinicopathological correlation suggested the diagnosis of DAL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Dasatinib was discontinued and the patient remained in close follow-up. TKI treatment with nilotinib was reinitiated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Lymphadenopathy resolved clinically at 4 weeks and normalization of PET\/CT findings was documented at 9 weeks after cessation of the drug. TKI treatment with nilotinib was reinitiated with good tolerance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>DAL may present with voluminous lymphadenopathy consistent with malignancy in clinical and imaging workup. We describe the spectrum of lesions associated with DAL and identify common features with drug-induced lymphadenopathy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022791","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T04:03:03Z","timestamp":1604548983000},"page":"e22791","source":"Crossref","is-referenced-by-count":11,"title":["Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient"],"prefix":"10.1097","volume":"99","author":[{"given":"Dimitrios","family":"Pilalas","sequence":"first","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Triantafyllia","family":"Koletsa","sequence":"additional","affiliation":[{"name":"Pathology Department, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[{"name":"3rd Department of Nuclear Medicine, Papageorgiou Hospital, Medical School, Aristotle University of Thessaloniki, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigorios","family":"Panselinas","sequence":"additional","affiliation":[{"name":"Pathology Department, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Exadaktylou","sequence":"additional","affiliation":[{"name":"3rd Department of Nuclear Medicine, Papageorgiou Hospital, Medical School, Aristotle University of Thessaloniki, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Polychronopoulos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Savopoulos","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-4500","authenticated-orcid":false,"given":"Georgia D.","family":"Kaiafa","sequence":"additional","affiliation":[{"name":"First Propedeutic Department of Internal Medicine, AHEPA University Hospital, Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00748.x","article-title":"Tyrosine kinases and their substrates in B lymphocytes","volume":"228","author":"Kurosaki","year":"2009","journal-title":"Immunol Rev"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/PAS.0000000000000488","article-title":"Dasatinib-related follicular hyperplasia","volume":"39","author":"Ozawa","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7493601","article-title":"Concurrent diagnosis of chronic myeloid leukemia and follicular lymphoma: an unreported presentation","volume":"2018","author":"Starr","year":"2018","journal-title":"Case Rep Hematol"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"e26597","DOI":"10.1002\/pbc.26597","article-title":"Dasatinib-associated follicular lymphoid hyperplasia: first pediatric case report and literature review","volume":"64","author":"Bouquet","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-017-3105-8","article-title":"Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia","volume":"96","author":"Iurlo","year":"2017","journal-title":"Ann Hematol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000375150","article-title":"Lymphoproliferative disorders in patients with chronic myeloid leukemia: a single-center case series","volume":"134","author":"Alshehry","year":"2015","journal-title":"Acta Haematol"},{"key":"R9-20230916","first-page":"288","article-title":"Benign lymphadenopathies in children and adolescents","volume":"12","author":"Segal","year":"1995","journal-title":"Semin Diagn Pathol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000478-199506000-00008","article-title":"Spectrum of histopathologic patterns","volume":"19","author":"Abbondanzo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2407-12-586","article-title":"GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers","volume":"12","author":"Hartmann","year":"2012","journal-title":"BMC Cancer"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s13139-017-0471-z","article-title":"Systemic Lupus Erythematosus Associated Pitfalls on 18F-FDG PET\/CT: reactive follicular hyperplasia, kikuchi-fujimoto disease, inflammation and lymphoid hyperplasia of the spleen mimicking lymphoma","volume":"52","author":"Makis","year":"2010","journal-title":"Nucl Med Mol Imaging"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7037352","article-title":"Drug-induced hypersensitivity syndrome: a clinical, radiologic, and histologic mimic of lymphoma","volume":"2018","author":"Gowani","year":"2018","journal-title":"Case Rep Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:53:09Z","timestamp":1694829189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022791"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":12,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022791","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}